- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.01. | Bayer taps Gabrielle Union-Wade as face of menopause med Lynkuet | ||
| 14.01. | Lenz ups Vizz visibility with DTC campaign starring Sarah Jessica Parker | ||
| 14.01. | Amneal and VantAI unveil fresh branding to kick off 2026 plans | ||
| 14.01. | FDA delays decision on Travere's Filspari in key kidney disease indication | ||
| 14.01. | JPM26: Novo Nordisk CEO reflects on 'curse of a leader' as company looks to reassert GLP-1 footing | ||
| 13.01. | JPM26: Ionis, bolstered by strong launch of Tryngolza, doubles its sales projection in new indication to $2B | ||
| 13.01. | JPM26: Leo Pharma, hungry for more partnerships, looks to widen reach in rare dermatology diseases | ||
| 13.01. | FDA blesses Sentynl and Cyprium's Zycubo as 1st treatment for Menkes disease | ||
| 13.01. | AbbVie inks latest White House drug pricing deal, scoring tariff reprieve as it makes $100B US investment pledge | ||
| 12.01. | JPM26: Bristol Myers CEO to 'cast a broad net' as business development remains a top priority | ||
| 12.01. | Cellares to expand cell therapy factory-in-a-box to Europe with new Netherlands facility | ||
| 12.01. | JPM26: Apellis shares tumble with sales decline for eye disease treatment Syfovre | ||
| 12.01. | Atara, Pierre Fabre allege FDA about-face as agency hands down 2nd Ebvallo snub | ||
| 12.01. | Bristol Myers Squibb paves way for expansion of Camzyos to adolescent patients | ||
| 12.01. | AbbVie drops $175M on Ariz. drug-device plant as US investment tour rolls on | ||
| 09.01. | Putting patients first: from buzzword to business imperative | ||
| 09.01. | Athira Pharma roars into the new year with rebrand to LeonaBio | ||
| 09.01. | Orca rides $250M funding wave toward cancer cell therapy launch | ||
| 09.01. | J&J strikes MFN deal with Trump, reveals plan to build 2 US manufacturing sites | ||
| 09.01. | Insmed's 'blowout' Brinsupri sales beat fuels multi-blockbuster outlook | ||
| 09.01. | Novartis charts next US investment with plan for new radiopharma plant in Florida | ||
| 08.01. | Lilly touts promise of Zepbound-Taltz combo in patients with obesity and psoriatic arthritis | ||
| 08.01. | Vanda's shares drop after 2nd FDA rejection for Hetlioz in jet lag disorder | ||
| 08.01. | InflaRx to prune headcount by 30%, curb COVID drug spending in bid to advance new favorite asset izicopan | ||
| 08.01. | AstraZeneca taps Spain head Rick Suarez to lead US biopharma unit, head up $50B investment surge |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.